|
||
Address correspondence to Ulrich H. von Andrian, The CBR Institute for Biomedical Research, 200 Longwood Ave., Boston, MA 02115. Phone: (617) 278-3130; Fax: (617) 278-3190; email: uva{at}cbr.med.harvard.edu
| Abstract |
|---|
|
|
|---|
20% of wild-type (WT) levels, whereas homing of naive T cells was reduced by 95%. Accordingly, a large fraction of endogenous CD8+ T cells in plt/plt PLNs displayed a TCM phenotype. Intravital microscopy of plt/plt subiliac lymph nodes showed that TCM rolled and firmly adhered (sticking) in high endothelial venules (HEVs), whereas naive T cells were incapable of sticking. Sticking of TCM in plt/plt HEVs was pertussis toxin sensitive and was blocked by anti-CXCL12 (SDF-1
). Anti-CXCL12 also reduced homing of TCM to PLNs in WT animals by 20%, indicating a nonredundant role for this chemokine in the presence of physiologic CCR7 agonists. Together, these data distinguish naive T cells from TCM, whereby only the latter display greater migratory flexibility by virtue of their increased responsiveness to both CCR7 ligands and CXCL12 during homing to PLN.
Key Words: lymphocytes chemokines migration secondary lymphoid organs recirculation
The present address of J.V. Stein is National Center for Biotechnology, CNB/CSIC, 28049 Madrid, Spain.
The present address of W. Weninger is The Wistar Institute, Philadelphia, PA 19104.
Abbreviations used in this paper: GFP, green fluorescent protein; GPCR, G
i-protein coupled receptor; HEV, high endothelial venule; IVM, intravital microscopy; MLN, mesenteric LN; PLN, peripheral LN; plt, paucity of lymph node T cells; PTX, pertussis toxin; TCM, central memory T cells; TEM, effector memory T cells; TRITC, tetramethylrhodamine-5-isothiocyanate.
| Introduction |
|---|
|
|
|---|
The localization of TCM in LNs might further contribute to their key role in immune protection. Professional APCs, in particular DCs, transport Ag from the periphery into the T cell zones of the LN (7). Thus, TCM are strategically positioned to interact with DCs, which provide optimal stimulatory signals if TCM detect a recall Ag on their surface.
We have recently described a method that allows for the generation of central memorylike CD8+ T cells in vitro (6). Ag-primed CD8+ T cells cultured in IL-15 for 57 d express high levels of CD44, L-selectin, and CCR7. Upon TCR stimulation, they produce IFN-
, but are not acutely cytotoxic in vitro. After adoptive transfer, these cells survive for long periods of time, and mount rapid Ag-specific recall responses. We have shown that these cells migrate to all secondary lymphoid organs, including peripheral LNs (PLNs), mesenteric LNs (MLNs), Peyer's patches, and spleen (8). Similar to naive T cells, migration to PLNs occurred via high endothelial venules (HEVs) and depended on L-selectin (8).
To address the role of CCR7 in PLN homing, TCM were injected into paucity of lymph node T cells (plt/plt) mice in which the lymphoid organexpressed CCR7 ligands CCL19 (ELC) and CCL21-Ser (SLC) are deleted (912). The few T cells present in plt/plt PLNs are enriched for memory cells (10), shown here to be predominantly TCM, indicating that this subset can home to LNs in the absence of CCR7 ligands. Indeed, although naive T cell homing was reduced to 5%, TCM migration to plt/plt PLNs was reduced to only 20% of WT levels (8). This suggests involvement of one or more CCR7-independent pathways that enable at least some TCM to home to PLNs.
In this paper, we show that TCM rolled and adhered firmly in plt/plt PLN HEVs. TCM sticking and migration to plt/plt PLNs were pertussis toxin (PTX) sensitive and CXCL12 dependent. Homing of TCM to WT PLNs was also partially dependent on CXCL12. In contrast, CXCL12 had no detectable effect on naive T cell trafficking to PLNs. Thus, TCM use at least two different chemokine pathways, CCR7CCL19/21 and CXCR4CXCL12, to enter PLNs under steady state conditions.
| Materials and Methods |
|---|
|
|
|---|
Reagents
Fluorochrome-labeled mAbs were obtained from BD Biosciences as follows: CD3
, CD4, CD8
, CD44, CD25, L-selectin, CD122, CD69, and TCRß. To detect CCR7 and P-selectin ligand expression, recombinant human CCL19-Ig and P-selectinIg chimeras were used (6). Antimurine CXCL12, recombinant murine CXCL12, CCL2, CCL5, CCL19, and recombinant human IL-15 were obtained from R&D Systems. PTX was obtained from Calbiochem.
In Vitro Differentiation of TCM
TCM were generated as described previously (6). In brief, splenocytes were incubated with 1 µg/ml anti-CD3
and 2 d later with media containing 20 ng/ml IL-15 (for 58 d). Before each experiment, activation marker and homing molecule expression were assessed by flow cytometry (8).
ELISA and Immunofluorescence
PLNs were removed from WT and plt/plt mice, homogenized in lysis buffer (radioimmunoprecipitation assay buffer with 1 mM PMSF, 10 µg/ml aprotinin, and 10 µg/ml leupeptin), and centrifuged (14k g at 4°C for 10 min). The supernatant was assayed for CXCL12 immunoreactivity by ELISA (R&D Systems). Immunostaining of frozen sections was performed as described previously (14).
Homing Assays
Homing assays were performed as described previously (8). In brief, tetramethylrhodamine-5-isothiocyanate (TRITC)-labeled TCM were mixed with LN cells from T-GFP mice and injected i.v. into recipients. After 1 or 24 h, 1 ml PBLs, spleen, PLNs, and MLNs were harvested, immunostained, and analyzed by flow cytometry. The homing index in organs was calculated as the ratio between the number of CD8+TRITC+ (TCM) and CD8+GFP+ (naive) T cells divided by the ratio of CD8+TRITC+ and CD8+GFP+ cells in the input (8). In some experiments, TCM were pretreated with 100 ng/ml PTX for 2 h before adoptive transfer. For blocking experiments, 100 µg/mouse anti-CXCL12 or control mAb were injected i.v. 15 min before adoptive transfer of T cells.
Intravital Microscopy and Image Analysis
Subiliac LN Preparation.
Surgical preparation of LNs was performed as described previously (15). TCM were labeled with calcein (Molecular Probes), and small boli of cells were injected intraarterially. T cellendothelial cell interactions in subiliac LNs downstream from the injection site were recorded. For experiments testing the role of CXCL12, cell behavior was analyzed in the same vessels before and after mAb injection. To assess the role of G
i-protein coupled receptors (GPCRs), PTX-treated and untreated TCM were compared.
Cremaster Muscle Preparation.
Cremaster muscles of C57BL/6 mice were prepared as described previously (16). Calcein-labeled TCM were injected, and several postcapillary and small collecting venules were recorded during a 15-min control period to determine baseline rolling and sticking. Subsequently, superfusion buffer was replaced with buffer containing 100 nM CXCL12, and TCM behavior was recorded in the same vessels for an additional 15 min.
Offline frame-by-frame video analysis was performed as described previously (17). Rolling fraction was determined as the percentage of cells interacting with HEVs in the total number of cells passing through a vessel during the observation period. Sticking fraction was defined as the percentage of rolling cells that adhered in HEVs for
30 s.
Statistical Analysis.
All data are presented as mean ± SEM. Homing indices were compared using the unpaired Student's t test. Rolling and sticking fractions were compared using the paired Student's t test.
| Results and Discussion |
|---|
|
|
|---|
|
TCM Roll and Stick in plt/plt HEVs.
There are two nonexclusive explanations for preferential TCM traffic to plt/plt PLNs as follows: TCM may have the unique ability to interact with HEVs by responding to an integrin-activating signal distinct from CCR7 ligands and/or they may enter via afferent lymphatic vessels. The latter mechanism was proposed by Mori et al., who observed delayed, but enhanced and prolonged T cellmediated immune responses to contact sensitizers in plt/plt PLNs (22). Due to CCL21-leu expression in lymphatic vessels in plt/plt mice, both T cells and DCs can enter these vessels to migrate to PLNs (11, 22, 23). However, we show here that several TCM accumulated in plt/plt PLNs as early as 1 h after i.v. injection. Given this brief interval, it seems unlikely that the homed cells could migrate to peripheral tissues and find their way into afferent lymphatics and from there into the cortex of draining LNs. Thus, our findings strongly suggest that TCM can enter plt/plt PLN from the blood.
To test this hypothesis, we used intravital microscopy (IVM) to analyze TCM behavior in the subiliac LN microcirculation of plt/plt mice. The venular tree of normal subiliac LNs consists of five successive venular branching orders, distinguishable by IVM (15). Order V represents postcapillary venules in the cortex and order I is the large collecting vessel at the LN hilus. In WT mice, naive T cells and TCM roll and stick mainly in order IIIV venules. These venules express the most peripheral node addressin, which mediates the rolling of L-selectin+ T cells (8, 18, 19, 24). Firm adhesion requires activation of the integrin LFA-1 on rolling lymphocytes, which is usually induced by CCR7 ligands displayed in HEVs (14).
plt/plt PLNs are smaller than WT PLNs and their microarchitecture is disorganized, but the venular tree is readily discernible by IVM in DDD/1-plt/plt PLNs, even though order V venules are typically absent (14). By contrast, BALB/c-plt/plt PLNs are not amenable to IVM because the rarefied venular tree in this strain is obscured by overlying B cell follicles (14). Calcein-labeled TCM were recorded in 43 HEVs (7 order I, 12 order II, 16 order III, and 8 order IV) in 6 DDD1-plt/plt mice (Fig. 2). Mean rolling fractions of TCM were 17 ± 5% (order I), 23 ± 3% (order II), 40 ± 5% (order III), and 33 ± 7% (order IV). This is comparable to rolling fractions of TCM in WT PLNs (8). For comparison, naive GFP+ T cells (14) were analyzed in 29 venules (2, order I; 8, order II; 8, order III; and 11, order IV) in seven mice. Their mean rolling fractions were 7 ± 2% (order I), 35 ± 9% (order II), 58 ± 4% (order III), and 59 ± 6% (order IV). Naive T cells rolled at similar frequencies in PLN HEVs of DDD/1-plt/plt and DDD/1-mtv/mtv mice, but completely failed to arrest in the former, indicating that CCR7 ligands are absolutely required (Fig. 2 and reference 14). However, TCM were unmistakably capable of sticking in DDD/1-plt/plt PLN HEVs (Fig. 2 B, mean sticking fractions: order I, 2.5 ± 1.8%; order II, 11.5 ± 3.3%; order III, 21.0 ± 4.4%; and order IV, 31.5 ± 1.8%). We conclude that integrins are efficiently activated on rolling TCM in plt/plt PLNs, indicating that an alternative chemoattractant pathway can be used by these cells. Moreover, HEVs are the likely port of PLN entry for TCM in plt/plt mice.
|
|
30% memory cells. Conceivably, CXCL12-responsive T cells recovered from plt/plt PLNs by Okada et al. may have contained a disproportionate fraction of TCM, rather than naive T cells, which predominate in WT PLNs. Normal expression of CXCL12 in plt/plt PLNs makes this a good candidate for CCR7-independent TCM migration to PLNs. Thus, we performed IVM of the subiliac LNs in DDD/1-plt/plt mice before and after anti-CXCL12 treatment. A total of 22 HEVs of orders III and IV in three DDD/1-plt/plt recipients were analyzed. Rolling fractions did not change after injection of anti-CXCL12 (Fig. 4 A, before: 25.0 ± 3.7%; after: 30.7 ± 5.0%; P > 0.05). In contrast, anti-CXCL12 markedly reduced the sticking fraction of TCM from 11.9 ± 2.8% to 2.6 ± 1.2% (Fig. 4 B, P < 0.01).
|
30% lower than in control mice (Fig. 4 D, P < 0.05). We also performed competitive homing experiments using naive GFP+ T cells and TRITC-labeled TCM in DDD/1-plt/plt mice after anti-CXCL12 or control mAb injection (n = 2). Anti-CXCL12 did not alter the low number of naive T cells that homed to PLNs (unpublished data). However, consistent with the aforementioned data, the homing index decreased from 1.4 ± 0.1 to 1.0 ± 0.2, indicating that TCM, but not naive T cells, home to PLNs in a partially CXCL12-dependent fashion. In contrast with DDD/1-plt/plt mice, anti-CXCL12 had no significant effect on TCM homing to BALB/c-plt/plt PLNs (Fig. 4 C). As a possible explanation for this apparent discrepancy, we asked whether PLN HEVs in BALB/c-plt/plt mice present less CXCL12 on their luminal surface than their counterparts in DDD/1-plt/plt. However, ELISA of PLN lysates and immunostaining of frozen PLN sections from both strains did not reveal detectable differences in CXCL12 protein content and expression pattern, at least at the light microscopic level (unpublished data). Therefore, it is more likely that the lack of CXCL12 contribution to TCM homing in BALB/c-plt/plt mice occurred because the venular tree in PLNs of this strain is very poorly developed compared with that in DDD/1-plt/plt (14). The available HEV surface area in the former may simply be too small to permit effective TCM recruitment, despite CXCL12 expression. This explanation is consistent with the finding that the absolute number of TCM that homed to BALB/c-plt/plt PLNs was three times lower than that recovered from DDD/1-plt/plt PLNs (85 ± 20 homed TCM/106 injected cells versus 267 ± 116/106 injected cells, respectively; P = 0.05; Fig. 4, C and D, and not depicted). Because our competitive homing experiments indicate that some TCM home to BALB/c-plt/plt PLNs in a CCR7-independent fashion (Fig. 1 A), it is likely that one or more other chemoattractants may be expressed in PLN HEVs of BALB/c-plt/plt mice that mediate TCM homing. The existence of additional GPCR-dependent recruitment signals appears likely, even in DDD/1 mice because PTX treatment blocked TCM homing to PLNs in both plt/plt strains more completely than anti-CXCL12 (Fig. 3 B). Because in vitrogenerated TCM respond to CCL2 (monocyte chemoattractant protein1) and CCL5 (regulated on activation, normal T cell expressed, and secreted [RANTES]; reference 8), we tested whether these chemokines contribute to TCM homing to BALB/c-plt/plt PLNs. Furthermore, very low levels of CCL21-leu mRNA have been detected in plt/plt mice (27). Therefore, we desensitized TCM with a 40-min incubation in 1 µM CCL2, CCL5, or CCL19 before adoptive transfer. The desensitized cells homed to BALB/c-plt/plt PLNs as efficiently as control cells (unpublished data), indicating that these chemokines do not play a role here. Other possible candidates include CXCR3 and its ligands as well as lipid chemoattractants, such as LTB4, which contribute to effector T cell homing to sites of inflammation (28). However, homing of CXCR3/ TCM was identical to that of WT TCM (unpublished data), and TCM do not chemotax toward LTB4 gradients (28). Thus, the nature of other chemoattractants involved in CCR7-independent TCM homing to PLNs remains to be identified.
Together, these results strongly suggest that CXCL12CXCR4 triggers integrin activation on rolling TCM, but not on naive T cells, in PLN HEVs of DDD/1-plt/plt mice. This pathway accounts for a significant fraction of TCM that home to PLNs. In addition, there is probably at least one other PTX-sensitive recruitment signal whose identity remains to be uncovered.
A Physiological Role for CXCL12 in TCM Homing to PLNs.
Given the severely disturbed architecture of secondary lymphoid organs in plt/plt mice (9, 10), we asked whether the observed contribution by CXCL12 to TCM migration reflects a truly physiological event. Therefore, we examined the effect of CXCL12 inhibition on TCM homing to WT PLNs. Indeed, homing was moderately by
20%, but significantly, reduced (Fig. 4 E, P < 0.05). This reduction in homing occurred in both C57BL/6 and BALB/c mice, indicating that the role of CXCL12 in WT mice may not depend on genetic modifiers.
We conclude that the CCR7 pathway plays a dominant role in TCM homing to PLNs, but CXCL12 also contributes to this process. Our finding that this nonredundant effect of CXCL12 is specific for TCM is also supported by earlier conclusions that CXCR4 deficiency does not reduce the ability of naive T cells to home to PLNs that express normal CCR7 ligands (20).
CXCL12 Induces Firm Adherence of TCM, But Not Naive T Cells, in Cremaster Muscle Venules.
Why are naive T cells apparently incapable of using CXCL12 for homing to PLNs? Naive T cells respond to CXCL12 gradients in chemotaxis assays at least as efficiently as TCM (unpublished data). Furthermore, CXCL12 induces LFA-1mediated adhesion of human naive T cells to ICAM-1 in flow chamber assays (29). In contrast, murine naive T cells fail to arrest in cremaster muscle venules upon CXCL12 superfusion, but undergo immediate arrest in muscles superfused with CCL21 (16).
Because our homing data also indicate that CXCL12 fails to attract naive T cells to PLNs, but can recruit TCM, we performed IVM to determine whether circulating TCM can respond to CXCL12 in situ. To this end, we asked whether CXCL12 superfusion induces TCM sticking in cremaster muscle venules (16). Fluorescently labeled TCM were injected intraarterially and their interactions with cremaster muscle venules were recorded. Without CXCL12 superfusion, the mean rolling and sticking fractions were 18.3 ± 5.0% and 1.3 ± 0.9%, respectively (n = 3 mice/30 vessels). Upon subsequent superfusion with CXCL12, rolling fractions remained unchanged (Fig. 5 A, 23.9 ± 3.0%, P > 0.05). In contrast, the TCM sticking fraction was significantly increased (Fig. 5 B, 6.9 ± 1.8%, P < 0.05 vs. control). To determine whether this was an effect of CXCL12 on the venular endothelium or on circulating TCM, we desensitized TCM to CXCL12 before injection. Desensitized TCM rolled similarly to untreated cells, but were incapable of sticking (Fig. 5, A and B). Thus, TCM, unlike naive T cells, are responsive to CXCL12 displayed on venular endothelium.
|
What might be the functional relevance of CCR7-independent homing of TCM to PLNs? Wherry et al. have recently shown that CD8+ effector CTL can give rise to TEM, which differentiate into L-selectin+ TCM over the course of several weeks (5). Effector CTL and TEM do not express L-selectin and CCR7 (4, 6, 8). Although the kinetics of L-selectin and CCR7 induction on TEM in the course of their transition into TCM is unknown, it has been shown that some Ag-experienced T cells express L-selectin but not CCR7 (4). For this subset, expression of CXCR4 could provide an alternative pathway to gain CCR7-independent access to PLNs. Moreover, CXCL12 is constitutively expressed in many tissues, especially in the BM, and is up-regulated during inflammation. In addition, human TCM isolated ex vivo, and murine TCM generated in vitro express several inflammatory chemokine receptors (4, 8). This broad expression pattern of chemokine receptors provides TCM with maximum flexibility to survey not only secondary lymphoid organs but also multiple other sites in the body.
| Acknowledgments |
|---|
T.W. Felbinger was supported by a research stipend from the Deutsche Forshungsgemeinschaft. W. Weninger was supported by an Erwin-Schrödinger Auslandstipendium from the Austrian Science Foundation and by a Pilot and Feasibility grant from the Harvard Skin Disease Research Center. U.H. von Andrian was supported by National Institutes of Health grants HL48675, HL54936, and HL56949.
Submitted: 23 September 2003
Accepted: 4 March 2004
| References |
|---|
|
|
|---|
1 Sprent, J., and C.D. Surh. 2002. T cell memory. Annu. Rev. Immunol. 20:551579.[CrossRef][Medline]
2 Kaech, S.M., E.J. Wherry, and R. Ahmed. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2:251262.[CrossRef][Medline]
3 Weninger, W., N. Manjunath, and U.H. von Andrian. 2002. Migration and differentiation of CD8+ T cells. Immunol. Rev. 186:221233.[CrossRef][Medline]
4 Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 401:708712.[CrossRef][Medline]
5 Wherry, E.J., V. Teichgraber, T.C. Becker, D. Masopust, S.M. Kaech, R. Antia, U.H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4:225234.[CrossRef][Medline]
6 Manjunath, N., P. Shankar, J. Wan, W. Weninger, M.A. Crowley, K. Hieshima, T.A. Springer, X. Fan, H. Shen, J. Lieberman, and U.H. von Andrian. 2001. Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J. Clin. Invest. 108:871878.[CrossRef][Medline]
7 Banchereau, J., and R.M. Steinman. 1998. Dendritic cells and the control of immunity. Nature. 392:245252.[CrossRef][Medline]
8 Weninger, W., M.A. Crowley, N. Manjunath, and U.H. von Andrian. 2001. Migratory properties of naive, effector, and memory CD8+ T cells. J. Exp. Med. 194:953966.
9 Nakano, H., T. Tamura, T. Yoshimoto, H. Yagita, M. Miyasaka, E.C. Butcher, H. Nariuchi, T. Kakiuchi, and A. Matsuzawa. 1997. Genetic defect in T lymphocyte-specific homing into peripheral lymph nodes. Eur. J. Immunol. 27:215221.[Medline]
10 Nakano, H., S. Mori, H. Yonekawa, H. Nariuchi, A. Matsuzawa, and T. Kakiuchi. 1998. A novel mutant gene involved in T-lymphocyte-specific homing into peripheral lymphoid organs on mouse chromosome 4. Blood. 91:28862895.
11 Luther, S.A., H.L. Tang, P.L. Hyman, A.G. Farr, and J.G. Cyster. 2000. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc. Natl. Acad. Sci. USA. 97:1269412699.
12 Vassileva, G., H. Soto, A. Zlotnik, H. Nakano, T. Kakiuchi, J.A. Hedrick, and S.A. Lira. 1999. The reduced expression of 6Ckine in the plt mouse results from the deletion of one of two 6Ckine genes. J. Exp. Med. 190:11831188.
13 Manjunath, N., P. Shankar, B. Stockton, P.D. Dubey, J. Lieberman, and U.H. von Andrian. 1999. A transgenic mouse model to analyze CD8+ effector T cell differentiation in vivo. Proc. Natl. Acad. Sci. USA. 96:1393213937.
14 Stein, J.V., A. Rot, Y. Luo, M. Narasimhaswamy, H. Nakano, M.D. Gunn, A. Matsuzawa, E.J. Quackenbush, M.E. Dorf, and U.H. von Andrian. 2000. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J. Exp. Med. 191:6176.
15 von Andrian, U.H. 1996. Intravital microscopy of the peripheral lymph node microcirculation in mice. Microcirc. 3:287300.[Medline]
16 Weninger, W., H.S. Carlsen, M. Goodarzi, F. Moazed, M.A. Crowley, E.S. Baekkevold, L.L. Cavanagh, and U.H. von Andrian. 2003. Naive T cell recruitment to non-lymphoid tissues: a role for endothelium-expressed CCL21 in autoimmune disease and lymphoid neogenesis. J. Immunol. 170:46384648.
17 von Andrian, U.H., and C. M'Rini. 1998. In situ analysis of lymphocyte migration to lymph nodes. Cell Adhes. Commun. 6:8596.[Medline]
18 von Andrian, U.H., and T.R. Mempel. 2003. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3:867878.[CrossRef][Medline]
19 Warnock, R.A., S. Askari, E.C. Butcher, and U.H. von Andrian. 1998. Molecular mechanisms of lymphocyte homing to peripheral lymph nodes. J. Exp. Med. 187:205216.
20 Okada, T., V.N. Ngo, E.H. Ekland, R. Forster, M. Lipp, D.R. Littman, and J.G. Cyster. 2002. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J. Exp. Med. 196:6575.
21 Zhang, X., S. Sun, I. Hwang, D.F. Tough, and J. Sprent. 1998. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity. 8:591599.[CrossRef][Medline]
22 Mori, S., H. Nakano, K. Aritomi, C.R. Wang, M.D. Gunn, and T. Kakiuchi. 2001. Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses. J. Exp. Med. 193:207218.
23 Nakano, H., and M.D. Gunn. 2001. Gene duplications at the chemokine locus on mouse chromosome 4: multiple strain-specific haplotypes and the deletion of secondary lymphoid-organ chemokine and EBI-1 ligand chemokine genes in the plt mutation. J. Immunol. 166:361369.
24 Stockton, B.M., G. Cheng, N. Manjunath, B. Ardman, and U.H. von Andrian. 1998. Negative regulation of T cell homing by CD43. Immunity. 8:373381.[CrossRef][Medline]
25 Springer, T.A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multi-step paradigm. Cell. 76:301314.[CrossRef][Medline]
26 Spangrude, G.J., B.A. Braaten, and R.A. Daynes. 1984. Molecular mechanisms of lymphocyte extravasation. I. Studies of two selective inhibitors of lymphocyte recirculation. J. Immunol. 132:354362.[Abstract]
27 Gunn, M.D., S. Kyuwa, C. Tam, T. Kakiuchi, A. Matsuzawa, L.T. Williams, and H. Nakano. 1999. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189:451460.
28 Goodarzi, K., M. Goodarzi, A.M. Tager, A.D. Luster, and U.H. Von Andrian. 2003. Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat. Immunol. 4:965973.[CrossRef][Medline]
29 Campbell, J.J., J. Hedrick, A. Zlotnik, M.A. Siani, D.A. Thompson, and E.C. Butcher. 1998. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science. 279:381384.
30 Kaech, S.M., S. Hemby, E. Kersh, and R. Ahmed. 2002. Molecular and functional profiling of memory CD8 T cell differentiation. Cell. 111:837851.[CrossRef][Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|